Dopamine Uses the DRD5-ARRB2-PP2A Signaling Axis to Block the TRAF6-Mediated NF-κB Pathway and Suppress Systemic Inflammation.
Journal: Molecular Cell
Published: 2020-01-29
DOI: 10.1016/j.molcel.2020.01.022
Affiliations: 8
Go to articleJournal: Molecular Cell
Published: 2020-01-29
DOI: 10.1016/j.molcel.2020.01.022
Affiliations: 8
Go to article